EPS Bio Technology Corp. manufactures and sells OEM/ODM glucose meters and strips primarily in Taiwan. More Details
Flawless balance sheet with solid track record.
Share Price & News
How has EPS Bio Technology's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4183 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: 4183's weekly volatility (2%) has been stable over the past year.
7 Day Return
TW Medical Equipment
1 Year Return
TW Medical Equipment
Return vs Industry: 4183 underperformed the TW Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: 4183 underperformed the TW Market which returned 45.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is EPS Bio Technology's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StShould You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)
3 months ago | Simply Wall StWill EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?
4 months ago | Simply Wall StHere's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative
Is EPS Bio Technology undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 4183 (NT$20) is trading above our estimate of fair value (NT$18.09)
Significantly Below Fair Value: 4183 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 4183 is poor value based on its PE Ratio (21.6x) compared to the TW Medical Equipment industry average (20.4x).
PE vs Market: 4183 is poor value based on its PE Ratio (21.6x) compared to the TW market (17.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 4183's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 4183 is good value based on its PB Ratio (1.6x) compared to the TW Medical Equipment industry average (2.1x).
How is EPS Bio Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EPS Bio Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has EPS Bio Technology performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4183 has high quality earnings.
Growing Profit Margin: 4183's current net profit margins (4.8%) are higher than last year (4.1%).
Past Earnings Growth Analysis
Earnings Trend: 4183's earnings have grown by 10.6% per year over the past 5 years.
Accelerating Growth: 4183's earnings growth over the past year (14.8%) exceeds its 5-year average (10.6% per year).
Earnings vs Industry: 4183 earnings growth over the past year (14.8%) exceeded the Medical Equipment industry 9.9%.
Return on Equity
High ROE: 4183's Return on Equity (7.3%) is considered low.
How is EPS Bio Technology's financial position?
Financial Position Analysis
Short Term Liabilities: 4183's short term assets (NT$365.0M) exceed its short term liabilities (NT$124.3M).
Long Term Liabilities: 4183's short term assets (NT$365.0M) exceed its long term liabilities (NT$125.2M).
Debt to Equity History and Analysis
Debt Level: 4183's debt to equity ratio (7.4%) is considered satisfactory.
Reducing Debt: 4183's debt to equity ratio has reduced from 17.8% to 7.4% over the past 5 years.
Debt Coverage: 4183's debt is well covered by operating cash flow (208%).
Interest Coverage: 4183's interest payments on its debt are well covered by EBIT (18x coverage).
What is EPS Bio Technology current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4183's dividend (6%) is higher than the bottom 25% of dividend payers in the TW market (1.99%).
High Dividend: 4183's dividend (6%) is in the top 25% of dividend payers in the TW market (5.04%)
Stability and Growth of Payments
Stable Dividend: 4183 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 4183's dividend payments have increased, but the company has only paid a dividend for 9 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (129.4%), 4183's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
EPS Bio Technology has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
EPS Bio Technology Corp.'s company bio, employee growth, exchange listings and data sources
- Name: EPS Bio Technology Corp.
- Ticker: 4183
- Exchange: TPEX
- Founded: NaN
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: NT$476.000m
- Shares outstanding: 23.80m
- Website: https://epsbio.com
Number of Employees
- EPS Bio Technology Corp.
- No. 8, R&D Road III
- Hsinchu Science Park
- Hsinchu City
EPS Bio Technology Corp. manufactures and sells OEM/ODM glucose meters and strips primarily in Taiwan. It provides blood glucose monitoring systems under the MDT2, EME, EMMU, EMV2, MasterDrive, 2IN1, and R...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/22 08:36|
|End of Day Share Price||2021/06/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.